Dupilumab improves respiratory symptoms in patients with moderate-to-severe COPD with type 2 inflammation in phase 3 BOREAS trial

被引：0
|
作者：
Papi, Alberto [1 ]
Bhatt, Surya P. [2 ]
Rabe, Klaus F. [3 ,4 ]
Hanania, Nicola A. [5 ]
Vogelmeier, Claus F. [6 ]
Bafadhel, Mona [7 ]
Christenson, Stephanie A. [8 ]
Singh, Dave [9 ]
Laws, Elizabeth [10 ]
Maloney, Jennifer [11 ]
Lu, Xin [10 ]
Bauer, Deborah [10 ]
Bansal, Ashish [11 ]
Robinson, Lacey B. [12 ]
Abdulai, Raolat M. [12 ]
机构：
[1] Univ Ferrara, Ferrara, Italy
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] LungenClin Grosshansdorf, Grosshansdorf, Germany
[4] Christian Albrechts Univ Kiel, Airway Res Ctr North, German Ctr Lung Res, Grosshansdorf, Germany
[5] Baylor Coll Med, Houston, TX USA
[6] Philipps Univ Marburg, German Ctr Lung Res DZL, Marburg, Germany
[7] Kings Coll London, Kings Ctr Lung Hlth, London, England
[8] Univ Calif San Francisco, San Francisco, CA USA
[9] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, England
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Cambridge, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4786
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Dupilumab Improves Patient-Reported Outcomes (PROs) in a Phase 2 Study in Adults with Moderate-to-Severe Atopic Dermatitis
    Simpson, Eric
    Worm, Margitta
    Soong, Weily
    Blauvelt, Andrew
    Eckert, Laurent
    Wu, Richard
    Ardeleanu, Marius
    Graham, Neil
    Pirozzi, Gianluca
    Sutherland, E. Rand
    Mastey, Vera
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB167 - AB167
  • [42] PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients
    Reyes, Jenysbel de la C. Hernandez
    Morales, Orestes Santos
    Moreno, Laura Hernandez
    Alfonso, Pedro Pablo Pino
    Vinageras, Elia Neninger
    Montalvo, Julia Lilliam Knigths
    Sosa, Aliuska Aguilar
    Morera, Amnely Gonzalez
    Alvarez, Patricia Lorenzo-Luaces
    Venegas, Yadira Aguilar
    Concepcion, Mayelin Troche
    Perez, Loipa Medel
    Gonzalez, Yanela Santiesteban
    Fernandez, Lazara Garcia
    Rodriguez, Lorena Regueiro
    Abrahan, Amparo Macias
    Mon, Mayrel Labrada
    Monzon, Kalet Leon
    Hernandez, Danay Saavedra
    Ramos, Tania Crombet
    VACCINES, 2024, 12 (08)
  • [43] Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis
    Kyllönen, H
    Malmberg, P
    Remitz, A
    Rytilä, P
    Metso, T
    Helenius, I
    Haahtela, T
    Reitamo, S
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (02): : 192 - 197
  • [44] Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial
    Paller, A.
    Blauvelt, A.
    Pariser, D.
    Worrell, R.
    Soong, W.
    Hong, C.
    Zhang, R.
    Eckert, L.
    Gadkari, A.
    Hultsch, T.
    Bansal, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 69 - 69
  • [45] Assessing the Adequacy of the Evaluating Respiratory Symptoms in COPD Measure and Supplemental Asthma Items Among Patients with Moderate-to-Severe Asthma
    von Maltzahn, R.
    Murray, L.
    Syrad, H.
    Howell, T.
    Lee, L.
    Pascoe, S.
    Fowler, A.
    Nelsen, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
    Sher, Lawrence
    Soong, Weily
    Mina-Osorio, Paola
    Prescilla, Randy
    Chen, Zhen
    Bansal, Ashish
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
  • [47] Dupilumab for Adolescents With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 3, Randomized, Double-Blinded Trial
    Paller, A.
    Blauvelt, A.
    Pariser, D.
    Soong, W.
    Hong, H. C-H
    Zhang, R.
    Eckert, L.
    Gadkari, A.
    Hultsch, T.
    Bansal, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
  • [48] Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial
    Paller, Amy S.
    Blauvelt, Andrew
    Pariser, David M.
    Soong, Wiley
    Hong, H. Chih-ho
    Zhang, Rick
    Eckert, Laurent
    Gadkari, Abhijit
    Hultsch, Thomas
    Bansal, Ashish
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB195 - AB195
  • [49] Aclidinium Bromide Improves Static Lung Function And Hyperinflation In Patients With Moderate-To-Severe COPD
    Watz, H.
    Beeh, K.
    Magnussen, H.
    De Teresa, L.
    Jarreta, D.
    Caracta, C.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
    Shi, Tingting
    Wu, Shuning
    Chen, Rongshan
    Xie, Yaping
    Yin, Genquan
    He, Chunhui
    Liang, Cuiping
    Lu, Gen
    BMC PULMONARY MEDICINE, 2024, 24 (01):
12345